News

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...
Following a visit to Copenhagen, Denmark, to collaborate on enhancing urban health, the Bangkok Metropolitan Administration (BMA) and Novo Nordisk will launch the Cities for Better Health (CBH) ...
In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...
A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...
Hims & Hers Health (HIMS) is quickly becoming one of the most compelling stories in the market as an emerging powerhouse in the direct-to-consumer healthcare space. The stock has posted outsized gains ...
A long-term investor in Apple (AAPL) might be perfectly thrilled at the stock's performance. It has returned 663% over the past 10 years, compared with a return of 261% for the S&P 500 SPX. And ...
People in Business Absci recently announced the appointment of veteran biopharmaceutical executive Mary Szela to its board of directors. With decades of research and development and commercial lea ...
Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of ...
BENGALURU] European shares closed lower on Friday (Jul 11), as losses in banks and healthcare stocks weighed at the end of a ...
The April-June quarter was anything but ordinary for the US stock market, even as the S&P 500 plummeted 13 per cent in April ...
The investigational dual GLP-1 and amylin receptor agonist Amycretin demonstrated significant weight loss—up to 24% with ...